Summary.-Experiments were undertaken to investigate the early effects of DMBA or progesterone, or the two in combination, on DNA synthesis in rat mammary epithelial cells, and also to determine whether there was any correlation between the level of DNA synthesis observed in the first 96 hours after administration of DMBA, either alone or combined with progesterone, and subsequent tumour development.
It was found that DMBA alone caused an insignificant reduction in DNA synthesis in the first 96 hours, whereas progesterone significantly enhanced DNA synthesis. When the carcinogen and hormone were administered together, a greater rise was seen in the level of DNA synthesis than that occurring in rats treated only with DMBA, but the increase was not significantly greater than that in untreated animals. A two-way analysis of variance revealed no interaction between DMBA and progesterone in relation to mammary epithelial cell DNA synthesis.
Mammary neoplasms occurred only in the groups of rats which had received DMBA, either alone or in combination with progesterone. No correlation could be demonstrated between the extent of DNA synthesis observed in mammary glands biopsied between 6 and 96 hours after carcinogen administration and the occurrence of tumours in the host rats 135 days later.
PREVIOUS investigations have shown that exogenous progesterone, while not carcinogenic per se, significantly enhanced 7,1 2-dimethylbenz(a)anthracene (DMBA) mammary carcinogenesis in entire rats when hormone injections were begun either 2 days before or just after carcinogen administration (Jabara, 1967; Jabara and Harcourt, 1970) . In contrast, Welsch, Clemens and Meites (1968) reported that prolonged (25 days) treatment with progesterone before administering DMBA significantly inhibited mammary tumorigenesis. They suggested that the enhanced mammary development induced by prolonged progesterone pretreatment rendered the gland relatively refractory to carcinogen action. DNA synthesis has been reported to be markedly depressed in rat mammary gland for at least 4 days after administration of DMBA alone (Shimkin et al., 1967; Tominaga, Libby and Dao, 1970) . Marquardt, Bendich and Philips (1971) have shown that while DMBA will bind to hepatocyte nonreplicating DNA, the amount of bound DMBA increases three-fold during DNA synthesis, and Brookes and Lawley (1964) observed a close correlation between carcinogenicity and the amount of hydrocarbon bound to DNA in mouse skin. These observations suggest that the contrasting effects on DMBA mammary carcinogenesis of long or short pretreatment with progesterone might be related to the level of DNA synthesis in the glands at the time of feeding DMBA.
The present experiments were designed early effects on DNA into 6 groups (Tables I and II) removed by surgical biopsy, but, as part of a preliminary experiment, some animals in each group were killed and the mammary tissue removed at autopsy (Table II) . Biopsied rats were permitted to survive until their 185th day of age, i.e. 135 days after feeding the carcinogen. In the control animals, tritiated thymidine was injected intraperitoneally 2 hours before killing rats in the different stages of the oestrous cycle; the 2 most posterior mammary glands on the left side were removed at autopsy (Table I) .
Preparation of autoradiographs
Excised mammary tissue was flattened on a thin card and fixed in 10% buffered formalin. Serial sections, 4 ,um thick, were cut from each paraffin block and, to avoid counting the same cell twice, only every fourth section was used. Three sections per slide were mounted well towards one end of it, dried and deparaffinized. The slides were then dipped, under a Ilford safety light No. 904F, in Ilford K5 nuclear emulsion diluted 1 in 4 with metal distilled water and maintained at 46°C. After drying the slides for 1-2 hours in a black, dustproof, Perspex box, the slides were sealed in lightproof slide boxes (Clay-Adams Inc.) and exposed at 4°C. To allow for variation in labelling intensity, half the slides were developed in Agfa Neutol S after 20 days and the remainder after 40 days (Fig. 1) (Table II) . Analysis revealed that while the difference between the LENs in the former 2 groups was not significant (P > 0-10), the differences between Group 2 and each of the latter 2 progesterone-treated groups (3 and 4) were significant (P < 0 005 and P < 0*025, respectively). Progesterone significantly 20 increased the LEN not only compared with that in the DMBA-treated rats, but also compared with the untreated controls (Group 1), regardless of whether injections were begun at 25 or 48 days of age (P < 0u(1 and P < 0 05, respectively) ( Table II) . The difference between the LENs in the 2 hormnone-treated groups (3 and 4) was not significant (Table II) .
Effects of co?nbined DMBA/progesterone on LEN In the rats treated with both carcinogen and hormone, the LEN for Group 5 (DMBA + P-25) was lower, but not significantly so, than that for Group 6 (DMBA + P-2) (Table II) , and neither of these LENs was significantly higher than that obtained for the controls (Group 1), the difference between the LENs for Group 1 and 6 just failinig to reach significance at th-e 5% level (P 0.051). However, the LENs for Groups 5 and 6 were both significantly higher than that obtained for Group 2 (DMBA only) (P < 0-01 and P < 0*025, respectively) ( Table II With the exception of an adenoma arising in one rat in Group 6, histologically all the neoplasms were carcinomata (Table III) , the majority being adenocarcinomata and the remainder of a solid, poorly differentiated type (Jabara, 1967) .
DISCUSSION
Thymidine is incorporated only into cells undergoing DNA synthesis (Reichard and Estborn, 1951; Friedkin, Tilson and Roberts, 1956) , so that the number of cells labelled with tritiated thymidine per 2000 gives an estimate of the number of cells undergoing DNA synthesis at the particular time of tissue sampling. Shimkin et al. (1967) and Tominaga, Libby and Dao (1970) (Frei and Harsono, 1967; Bates Ut al., 1968; Hennings et al., 1968; Pound, 1968; Suss and Maurer, 1968 (Flesher, 1967; Goshman and Heidelberger, 1967; Janss, Moon and Irving, 1971) , and recent work suggests that early events in mammary carcinogenesis may be related to the effects of DMBA on DNA-dependent RNA polymerase activity (Tominaga et al., 1971) . These investigators observed a significant decrease in activity of this enzyme for 2 days after DMBA administration to female rats, and activity then increased to a level significantly above control values by 4 days. No depression in RNA polymerase activity occurred in male rats fed DMBA. These findings substantiate the alterations in RNA synthesis reported by Libby and Dao (1966) in female rat mammary glands within the same 4-day period. They also found that the depression in RNA synthesis occurred only in females and was dependent on the presence of ovarian steroids, particularly oestrogen. During pseudopregnancy, a progestational state, both DNA and RNA synthesis have been shown to be significantly enhanced in rat mammary tissue (Sinha and Schmidt, 1969) . While the effect of combined DMBA/progesterone administration on rat mammary gland RNA synthesis is not yet known, the present experiments failed to show any interaction between the carcinogen and hormone in relation to mammary epithelial cell DNA synthesis. This suggests that the two agents may be acting at separate sites within the mammary epithelial cell. Previous work, supporting this suggestion, has shown that while progesterone is a potent promotor of DMBA mammary carcinogenesis when administered close to the time of feeding the carcinogen, its presence does not appear to be essential for cancer induction (Jabara and Harcourt, 1970, 1971) . However, whether the carcinogen and hormone act initially at the transcriptional or translational level, or at both, is not yet certain. O'Malley and Toft (1971) and Spelsberg, Steggles and O'Malley (1971) have recently shown that tritiated progesterone is complexed with a cytosol receptor protein in chick oviduct and then transported to the nucleus where the progesterone-receptor complex binds to non-histone acidic proteins of oviduct chromatin. Whether progesterone also acts directly on rat mammary tissue in this way is unknown. Available evidence suggests that progesterone may stimulate breast tissue indirectly via the hypothalamus and pituitary gland, the effect being due to increased secretion of prolactin (LTH) and possibly also growth hormone (STH) (Huggins, Mainzer and Briziarelli, 1958; Rothchild, 1960; Kim, 1965; Clementi and De Virgiliis, 1967; Hervey and Hervey, 1967; Sar and Meites, 1968; Welsch et al., 1968) . Both LTH and STH have been shown to stimulate markedly mammary growth in rats, even in the absence of the pituitary gland and ovaries (Furth and Clifton, 1957; Talwalker and Meites, 1961; Dao and Gawlak, 1963; Talwalker, Meites and Mizuno, 1964; Sinha and Tucker, 1968; Takizawa, Furth and Furth, 1970) . Experiments are in progress in this laboratory to clarify this point.
